See more : Fifth Wall Acquisition Corp. III (FWAC) Income Statement Analysis – Financial Results
Complete financial analysis of Bluejay Diagnostics, Inc. (BJDX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bluejay Diagnostics, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Tomato Bank, Ltd. (8542.T) Income Statement Analysis – Financial Results
- Hofseth BioCare ASA (HOFBF) Income Statement Analysis – Financial Results
- Predilife S.A. (ALPRE.PA) Income Statement Analysis – Financial Results
- Orbit International Corp. (ORBT) Income Statement Analysis – Financial Results
- Centrum Capital Limited (CENTRUM.NS) Income Statement Analysis – Financial Results
Bluejay Diagnostics, Inc. (BJDX)
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 249.04K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 780.96K | 200.13K | 145.72K | 157.04K | 142.98K |
| Gross Profit | -780.96K | 48.91K | -145.72K | -157.04K | -142.98K |
| Gross Profit Ratio | 0.00% | 19.64% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.71M | 4.15M | 1.15M | 527.25K | 454.61K |
| General & Administrative | 4.31M | 4.76M | 1.79M | 596.12K | 884.00K |
| Selling & Marketing | 283.44K | 451.42K | 289.73K | 73.02K | 292.80K |
| SG&A | 4.60M | 5.21M | 2.08M | 669.14K | 1.18M |
| Other Expenses | 0.00 | 258.14K | -75.00K | 5.54K | 749.45K |
| Operating Expenses | 10.31M | 9.37M | 3.16M | 1.20M | 1.63M |
| Cost & Expenses | 10.31M | 9.57M | 3.16M | 1.20M | 1.63M |
| Interest Income | 164.90K | 89.67K | 513.30K | 143.67K | 52.28K |
| Interest Expense | 0.00 | 0.00 | 367.46K | 27.00K | 0.00 |
| Depreciation & Amortization | 780.96K | 306.37K | 145.72K | 157.04K | 142.98K |
| EBITDA | -9.17M | -8.99M | -3.08M | -1.04M | -1.49M |
| EBITDA Ratio | 0.00% | -3,637.82% | 0.00% | 0.00% | 0.00% |
| Operating Income | -10.31M | -9.32M | -3.23M | -1.20M | -1.63M |
| Operating Income Ratio | 0.00% | -3,741.48% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 357.33K | 20.83K | -258.14K | 38.11K | 811.57K |
| Income Before Tax | -9.95M | -9.30M | -3.49M | -1.16M | -819.84K |
| Income Before Tax Ratio | 0.00% | -3,733.11% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -69.06K | 241.39K | -32.57K | -62.13K |
| Net Income | -9.95M | -9.23M | -3.73M | -1.13M | -757.72K |
| Net Income Ratio | 0.00% | -3,705.38% | 0.00% | 0.00% | 0.00% |
| EPS | -72.62 | -73.22 | -29.67 | -14.19 | -9.55 |
| EPS Diluted | -72.62 | -73.22 | -29.67 | -14.19 | -9.55 |
| Weighted Avg Shares Out | 137.06K | 126.02K | 125.70K | 79.34K | 79.34K |
| Weighted Avg Shares Out (Dil) | 137.06K | 126.02K | 125.70K | 79.34K | 79.34K |
Why Is Bluejay Diagnostics (BJDX) Stock Up 17% Today?
Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Why Bluejay Diagnostics Shares Are Surging Higher Today
Penny Stocks To Buy Today? 3 To Watch With Analyst Targets Up To 675%
Best Penny Stocks For March 2022? 5 To Watch With Insider Buying
Bluejay Diagnostics (BJDX) Stock: Why The Price Jumped Up Today
Check These 3 Penny Stocks Out For Your Morning Watchlist
4 Top Penny Stocks To Watch With The Stock Market Down Today
Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch
Source: https://incomestatements.info
Category: Stock Reports